Medical Dialogues

Vemircopan Fails to Demonstrate Efficacy in myasthenia gravis in Phase 2 Trial

In a double-blind, placebo-controlled phase 2 randomized clinical trial, vemircopan did not meet the predefined efficacy ...

Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial

Dupixent showed significant and clinically meaningful improvements in both esophageal distensibility as well as disease-related structural ...
Le Lézard

Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease

Johnson & Johnson today announced Phase 2b data from two studies evaluating JNJ-4804, an investigational co-antibody therapy targeting both interleukin-23 (IL-23) and tumor necrosis factor-alpha (TNF- ...
Le Lézard

Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn's disease

Johnson & Johnson today announced results from the Phase 3 FUZION study evaluating TREMFYA® (guselkumab) in adults with active perianal fistulizing Crohn's disease (CD). At Week 24, TREMFYA ...

NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA

SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the ...

Electric double layer unlocks molecular switch behind battery and hydrogen reactions

From smartphone charging to hydrogen production, the fundamental principles of energy technology have been revealed. Korean ...
Electrek

ENGWE EP-2 3.0 folding commuter e-bike with $214 bundle at new $949 low, Baseus X1 Pro dual-tracking solar camera $150 low, more

Headlining this week’s starting Green Deals is a spotlight on the ENGWE EP-2 3.0 Fast Charging Long-Range Foldable Commuter ...